Thursday, May 14, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result

Palantir’s Ukraine Showcase Can’t Shake the Stock’s Valuation Hangover

SiterGedge by SiterGedge
May 14, 2026
in Uncategorized
0
Palantir Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Alex Karp’s face-to-face with Volodymyr Zelenskyy in Kyiv on Tuesday was everything Palantir could want from a product demonstration: a real war, real data, and a president grateful for the help. But back on Wall Street, the stock keeps bleeding. The same AI wizardry that drives drone intercepts and battlefield intelligence in Ukraine has pushed Palantir’s revenue into overdrive, yet the share price has surrendered more than a fifth of its value since January.

The meeting cemented Palantir’s role as the go-to platform for military AI. Zelenskyy called it a “good meeting” and praised the company’s global reputation. Defence Minister Mykhailo Fedorov highlighted three specific uses: analysing air strikes, processing reconnaissance data, and planning long-range operations. The backbone is Brave1 Dataroom, where more than 100 Ukrainian companies now train over 80 AI models — many focused on detecting and destroying aerial targets under conditions that no simulation can replicate. Palantir has been on the ground since June 2022, and its MetaConstellation software fuses satellite, drone and sensor feeds into a single operational picture. For the US and European defence ministries watching, it’s a live-fire demo that no PowerPoint can match.

Revenues rocket, pipeline doubles

That operational heft shows up in the numbers. First-quarter revenue surged 85% year-on-year to $1.633 billion — the fastest growth in at least six years — while US commercial revenue more than doubled, climbing 133%. Adjusted earnings per share blew past analyst estimates. The remaining contract value hit $11.8 billion, nearly double the prior year, and the GAAP margin reached 53%. Demand from government clients is so intense that Palantir is turning away commercial work because its teams simply can’t keep up.

Yet the stock closed Wednesday at €111.18, down roughly 4% on the session and 22.31% below its start to 2025. The distance from last November’s all-time high of €179.86 is widening. Investors are rotating out of high-multiple winners and into laggards, and Palantir remains a prime candidate for profit-taking.

Should investors sell immediately? Or is it worth buying Palantir?

The price of being a premium name

The valuation gap is glaring. Palantir trades at about 93 times forward earnings and 154 times trailing earnings — a massive premium over the rest of the software sector. Morningstar sees fair value at $153, citing high uncertainty around the addressable market and competition from OpenAI and Anthropic. The Wall Street consensus target sits at $183.73, with Argus recently reaffirming $190. But insider sales underscore the tension: executives have unloaded $432.1 million worth of shares over the past few months.

Adding to the complexity, Palantir’s deep ties to US intelligence carry a geopolitical cost. Swiss auditors flagged the risk of unauthorised data flows to America, prompting the Swiss army to cut ties with Palantir at the end of 2025. And the company’s work in Ukraine has reportedly landed Karp on a Kremlin death list, according to British media. Such headlines don’t help a stock already under valuation scrutiny.

What comes next

The next hard test arrives with the second-quarter report. Management guided for revenue between $1.797 billion and $1.801 billion. Karp has also projected that the US business will double again by 2027. Those are heady ambitions for a company whose share price is being held hostage by its own multiple. For now, Palantir remains a story of operational brilliance and market caution — a rare combination that will only resolve when earnings catch up to the price investors are being asked to pay.

Ad

Palantir Stock: Buy or Sell?! New Palantir Analysis from May 14 delivers the answer:

The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 14.

Palantir: Buy or sell? Read more here...

Tags: Palantir
SiterGedge

SiterGedge

Related Posts

IonQ Stock

IonQ Charts New Territory with Urban Planning and Radar as First 256-Qubit System Ships to Cambridge

May 13, 2026
Highland Critical Minerals Stock
Commodities

Highland Critical Minerals Secures C$400,000 for Summer Fieldwork Amid CIRO Probe and 47% Share Price Rout

May 13, 2026
SoftBank Stock

SoftBank Reports Historic ¥5 Trillion Profit, but a Funding Pullback Reveals Creeping Caution

May 13, 2026

Recommended

Green renewable

Canadian Solar Inc Reports Revenue Decline in Q4 2023 Expects Lower Revenue for Q1 2024

2 years ago
D-Wave Quantum Stock

D-Wave Quantum Executive Liquidates $2.5 Million in Stock Amid Rally

8 months ago
Deutz AG Stock

Deutz AG’s Cost-Cutting Drive Shows Tangible Results Amid Market Skepticism

1 month ago
EEFT stock news

Spirit of America Management Corp NY Trims Holdings in City Office REIT, Inc.

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

SoftBank Reports Historic ¥5 Trillion Profit, but a Funding Pullback Reveals Creeping Caution

Pharma Giants AstraZeneca and GSK Tap Onco-Innovations’ Causal AI to Sharpen Cancer Trial Predictions

Rocket Lab Transforms from Launch Specialist to Full-Scale Space Supplier as Orders Hit $2.2 Billion

With a 1-for-10 Split Behind It, WisdomTree’s Triple-Leveraged Silver Fund Faces Its Toughest Test Yet

Intel’s Nvidia Deal and $5 Billion Vote of Confidence Overshadowed by Market Headwinds

Quantum eMotion’s Taiwan Test Marks the First Step in a Quantum-Safe Energy Pivot

Trending

Palantir Stock

Palantir’s Ukraine Showcase Can’t Shake the Stock’s Valuation Hangover

by SiterGedge
May 14, 2026
0

Alex Karp’s face-to-face with Volodymyr Zelenskyy in Kyiv on Tuesday was everything Palantir could want from a...

IonQ Stock

IonQ Charts New Territory with Urban Planning and Radar as First 256-Qubit System Ships to Cambridge

May 13, 2026
Highland Critical Minerals Stock

Highland Critical Minerals Secures C$400,000 for Summer Fieldwork Amid CIRO Probe and 47% Share Price Rout

May 13, 2026
SoftBank Stock

SoftBank Reports Historic ¥5 Trillion Profit, but a Funding Pullback Reveals Creeping Caution

May 13, 2026
Onco-Innovations Stock

Pharma Giants AstraZeneca and GSK Tap Onco-Innovations’ Causal AI to Sharpen Cancer Trial Predictions

May 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Palantir’s Ukraine Showcase Can’t Shake the Stock’s Valuation Hangover
  • IonQ Charts New Territory with Urban Planning and Radar as First 256-Qubit System Ships to Cambridge
  • Highland Critical Minerals Secures C$400,000 for Summer Fieldwork Amid CIRO Probe and 47% Share Price Rout

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com